Clinical Trial Update: Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating toripalimab plus GP induction chemotherapy versus placebo with GP in locoregionally advanced nasopharyngeal carcinoma and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 3 | Status: RECRUITING